Home › DHA Speciality › Specialist Pulmonary Disease (PUL5081)

Master Specialist Pulmonary Disease (PUL5081)
for DHA Speciality

Access 285+ high-yield questions tailored for the 2026 syllabus. Includes AI-powered explanations and performance tracking.

Start Free Practice View Full Syllabus

Sample Practice Questions

Question 1 FULLY WORKED EXAMPLE

A 58-year-old man with a 40 pack-year smoking history presents with 3 weeks of progressive dyspnoea and a dry cough. He has no fever, no haemoptysis, and no weight loss. Chest radiograph shows a large right-sided pleural effusion. Thoracentesis yields 800 mL of bloody fluid; pleural fluid protein is 4.2 g/dL (serum protein 6.8 g/dL), LDH 520 U/L (serum LDH 210 U/L), glucose 4.8 mmol/L, pH 7.38, and cytology is negative for malignant cells on the first sample. CT thorax shows a pleural effusion with nodular pleural thickening and no parenchymal mass. What is the most appropriate next step in management?

A) Repeat thoracentesis with a second cytology sample
B) Insert an intercostal chest drain and request pleural biopsy ✓ Correct
C) Start empirical anti-tuberculous therapy
D) Reassure and arrange outpatient chest radiograph in 6 weeks
Explanation:
The deciding finding is the nodular pleural thickening on CT in a heavy smoker with a bloody exudative effusion and negative first cytology, which raises strong suspicion of malignant pleural mesothelioma or metastatic pleural malignancy. British Thoracic Society guidance on pleural disease states that when pleural fluid cytology is negative but imaging shows nodular pleural thickening, image-guided or thoracoscopic pleural biopsy is required, and a chest drain is placed at the same time to manage the effusion and allow talc pleurodesis if indicated. Repeating cytology alone is inadequate because a second sample adds little diagnostic yield once imaging is suspicious. Empirical anti-tuberculous therapy is wrong because the fluid is a bloody exudate with normal glucose and pH, and there is no fever or parenchymal disease to support tuberculosis. Simple reassurance and delayed radiography is unsafe given the nodular pleural thickening and high malignancy risk.
References: British Thoracic Society. Pleural Disease Guideline: Investigation of a unilateral pleural effusion in adults. Thorax.
Question 2 TRY IT — TAP AN ANSWER

A 34-year-old woman at 32 weeks' gestation presents with a 2-day history of progressive dyspnoea, pleuritic chest pain, and right calf swelling. Heart rate is 118/min, respiratory rate 24/min, blood pressure 108/68 mmHg, and SpO2 94% on room air. Compression ultrasound confirms a right popliteal deep vein thrombosis. She has no haemoptysis and no prior VTE. What is the most appropriate immediate management?

A) Start therapeutic low-molecular-weight heparin and arrange urgent echocardiography
B) Start therapeutic low-molecular-weight heparin and arrange urgent ventilation-perfusion (V/Q) scan
C) Start therapeutic low-molecular-weight heparin and arrange urgent CT pulmonary angiography
D) Withhold anticoagulation until the diagnosis of pulmonary embolism is confirmed
💡 Pick an answer above to see if you're right — the full explanation unlocks instantly.
Question 3 TRY IT — TAP AN ANSWER

A 62-year-old man with COPD (FEV1 42% predicted) presents with 4 days of increased breathlessness, increased sputum purulence, and increased sputum volume. He is alert, respiratory rate 26/min, SpO2 88% on room air, and arterial blood gas on room air shows pH 7.33, PaCO2 58 mmHg, PaO2 52 mmHg, and bicarbonate 30 mmol/L. Chest radiograph shows no consolidation or pneumothorax. He has no contraindication to non-invasive ventilation. What is the most appropriate next step in management?

A) Start controlled oxygen to target SpO2 94-98% and reassess in 1 hour
B) Start controlled oxygen to target SpO2 88-92% and commence non-invasive ventilation
C) Start controlled oxygen to target SpO2 88-92% and commence invasive mechanical ventilation
D) Start controlled oxygen to target SpO2 88-92% and commence intravenous doxapram
💡 Pick an answer above to see if you're right — the full explanation unlocks instantly.
Question 4 TRY IT — TAP AN ANSWER

A 45-year-old woman presents with a 6-month history of episodic wheeze, chest tightness, and dry cough, worse at night and after exercise. She has no fever, no weight loss, and no haemoptysis. Spirometry shows FEV1 78% predicted, FVC 92% predicted, and FEV1/FVC ratio 0.72; bronchodilator response shows a 9% and 180 mL improvement in FEV1. Fractional exhaled nitric oxide is 58 ppb. Chest radiograph is normal. What is the most appropriate next step in management?

A) Reassure and arrange repeat spirometry in 6 months
B) Start a trial of inhaled corticosteroid and reassess in 6-8 weeks
C) Start a trial of long-acting beta-2 agonist monotherapy
D) Arrange high-resolution CT thorax to exclude bronchiectasis
💡 Pick an answer above to see if you're right — the full explanation unlocks instantly.
Question 5 TRY IT — TAP AN ANSWER

A 70-year-old man with a history of hypertension and type 2 diabetes presents with 5 days of fever, productive cough, and right-sided pleuritic chest pain. Respiratory rate is 30/min, blood pressure 96/60 mmHg, heart rate 112/min, and SpO2 90% on room air. Chest radiograph shows right lower lobe consolidation with a small parapneumonic effusion. Blood urea is 9.8 mmol/L, and CURB-65 score is 3. What is the most appropriate disposition and initial management?

A) Admit to hospital and start oral amoxicillin
B) Admit to hospital and start intravenous co-amoxiclav plus clarithromycin
C) Manage as an outpatient with oral levofloxacin
D) Admit to intensive care and start intravenous ceftriaxone plus azithromycin
💡 Pick an answer above to see if you're right — the full explanation unlocks instantly.

Want 285+ more Specialist Pulmonary Disease (PUL5081) questions?

Start Free — No Card Needed

DHA Speciality

  • ✓ 285+ Specialist Pulmonary Disease (PUL5081) Questions
  • ✓ AI Tutor Assistance
  • ✓ Detailed Explanations
  • ✓ Performance Analytics
Get Full Access

Specialist Pulmonary Disease (PUL5081) Questions for DHA Speciality — FAQ

How many Specialist Pulmonary Disease (PUL5081) questions does MedLumen have for DHA Speciality?

MedLumen currently has 285+ Specialist Pulmonary Disease (PUL5081) practice questions for DHA Speciality, each with a detailed explanation so you understand the reasoning behind every answer.

Are the Specialist Pulmonary Disease (PUL5081) questions updated for the 2026 DHA Speciality syllabus?

Yes. Our Specialist Pulmonary Disease (PUL5081) questions are mapped to the latest DHA Speciality blueprint and reviewed regularly so they stay aligned with the current 2026 syllabus.

Can I practise Specialist Pulmonary Disease (PUL5081) questions for free?

You can preview sample Specialist Pulmonary Disease (PUL5081) questions for free. A MedLumen subscription unlocks all 285+ Specialist Pulmonary Disease (PUL5081) questions, full answer explanations, and performance analytics for DHA Speciality.

How should I revise Specialist Pulmonary Disease (PUL5081) for DHA Speciality?

Practise Specialist Pulmonary Disease (PUL5081) questions in timed blocks, read the explanation for every answer (right or wrong), and use MedLumen's analytics to revisit your weak areas until your accuracy is consistently high.

Prepare for DHA Speciality with MedLumen →